Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Chugai discloses antiischemic agents

Nov. 15, 1996

FDA approves once-daily antihypertensive combination

Nov. 15, 1996

Biovail licenses once-daily diltiazem

Nov. 15, 1996

Endothelin antagonists claimed by E. Merck

Nov. 15, 1996

Fujisawa describes ACE and/or NEP inhibitors

Nov. 15, 1996

Dual ACE/NEP inhibitors from Fujisawa

Nov. 15, 1996

Potential antiischemic/antiarrhythmic agent reported

Nov. 8, 1996

Suntory's new sodium/calcium channel blockers

Nov. 8, 1996

Second-generation nitroglycerin patch submitted in Spain

Nov. 8, 1996

Development of Scotia's restenosis Rx back on track

Nov. 8, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...